Evidence map›Paper›PMID 34063716›Full record

ArticleInternational journal of molecular sciences2021

A Proteomic Approach for Systematic Mapping of Substrates of Human Deubiquitinating Enzymes.

Juanma Ramirez, Gorka Prieto, Anne Olazabal-Herrero, Eva Borràs, Elvira Fernandez-Vigo, Unai Alduntzin, Nerea Osinalde, Javier Beaskoetxea, Benoit Lectez, Kerman Aloria and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin-proteasome pathway.Protein science : a publication of the Protein Society · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Juanma RamirezDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-8500-7521
Gorka PrietoDepartment of Communications Engineering, University of the Basque Country (UPV/EHU), 48013 Bilbao, Spain.ORCID 0000-0002-6433-8452
Anne Olazabal-HerreroDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Eva BorràsCenter for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain.ORCID 0000-0001-5100-7809
Elvira Fernandez-VigoProteomics Unit, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.
Unai AlduntzinDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Nerea OsinaldeDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Javier BeaskoetxeaDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Benoit LectezDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0001-9796-1606
Kerman AloriaProteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0001-7268-7700
Jose Antonio RodriguezDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-2823-3733
Alberto ParadelaFunctional Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), ProteoRed-ISCIII, 28029 Madrid, Spain.
Eduard SabidóCenter for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain.ORCID 0000-0001-6506-7714
Javier MuñozProteomics Unit, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.
Fernando CorralesFunctional Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), ProteoRed-ISCIII, 28029 Madrid, Spain.ORCID 0000-0002-0231-5159
Jesus M ArizmendiDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-1412-4042
Ugo MayorDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0003-2812-8287
University of the Basque Country · ESCentro Nacional de Biotecnología · ESSpanish National Cancer Research Centre · ESUniversitat Pompeu Fabra · ESIkerbasque · ES

Funding

Instituto de Salud Carlos III IPT17/0019
6 · The paper itself

Abstract

The human genome contains nearly 100 deubiquitinating enzymes (DUBs) responsible for removing ubiquitin moieties from a large variety of substrates. Which DUBs are responsible for targeting which substrates remain mostly unknown. Here we implement the

Indexed as

ProteomicsDatabases, GeneticDeubiquitinating EnzymesHumansProteomeSubstrate SpecificityUbiquitinUbiquitinationDeubiquitinating EnzymesProteomeUbiquitindeubiquitinating enzymeDUBasequantitative proteomicsubiquitination

Identifiers

PMID34063716
PMCPMC8124392
OpenAlexW3158343580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.